...
首页> 外文期刊>International Journal of Pharmaceutics >Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
【24h】

Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.

机译:低毒两亲壳聚糖衍生物的合成,表征及其作为抗肿瘤药的胶束载体的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of amphiphilically modified chitosan molecules with long alkyl chains as hydrophobic moieties and glycol groups as hydrophilic moieties (N-octyl-O-glycol chitosan, OGC) was synthesized for use as drug carriers. The chemical structure was characterized by Fourier transform infrared, (1)H nuclear magnetic resonance, and elemental analysis. OGC could easily self-assemble to form nanomicelles in an aqueous environment and exhibited a low critical micellar concentration of 5.3-32.5mg/L. The biocompatibility and low toxicity of OGC as excipient for the dosage forms aimed at i.v. administration were confirmed by hemolysis, acute toxicity and histopathological studies. Furthermore, the possibility of solubilizing paclitaxel (PTX), a water-insoluble antitumor drug, with OGC micelles was also explored. PTX was successfully loaded into OGC micelles by using a simple dialysis process. The drug-loading capacity of OGC and stability of drug-loaded micelles were significantly affected by the degree of substitution of alkyl chains. Moreover, a series of safety studies including hemolysis, hypersensitivity, maximum tolerated dose, acute toxicity, and organ toxicity revealed that the PTX-loaded OGC micelles had advantages over the commercially available injectable preparation of PTX (Taxol((R))), in terms of low toxicity levels and increased tolerated dose. Additionally, cytotoxicity studies showed that the PTX-loaded OGC micelles were comparable to the commercial formulation, but the blank micelles were far less toxic than the Cremophor EL vehicle. These results suggest that OGC is a promising carrier for injectable PTX micelles.
机译:合成了一系列新的两亲改性的壳聚糖分子,其长链为疏水部分,二醇基为亲水部分(N-辛基-O-乙二醇壳聚糖,OGC)用作药物载体。通过傅里叶变换红外光谱,(1)H核磁共振和元素分析对化学结构进行表征。 OGC可以很容易地在水性环境中自组装形成纳米胶束,并且其临界胶束浓度较低,为5.3-32.5mg / L。 OGC作为针对静脉内剂型的赋形剂的生物相容性和低毒性。溶血,急性毒性和组织病理学研究证实给药。此外,还探索了用OGC胶束增溶水不溶性抗肿瘤药紫杉醇(PTX)的可能性。通过简单的透析过程,PTX已成功加载到OGC胶束中。 OGC的载药量和载药胶束的稳定性受烷基链取代程度的影响。此外,包括溶血,超敏反应,最大耐受剂量,急性毒性和器官毒性在内的一系列安全性研究表明,载有PTX的OGC胶束比市售的PTX注射制剂(Taxol(R))具有优势。低毒性水平和增加的耐受剂量。此外,细胞毒性研究表明,装载PTX的OGC胶束与市售制剂相当,但空白胶束的毒性远低于Cremophor EL载体。这些结果表明OGC是可注射PTX胶束的有希望的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号